STANT

Private

OssHealthcare & Life Scienceshttps://stant-biotech.com/

Last Round

Seed

Nov 19, 2024

Company Overview

STANT is a biotechnology company developing proprietary inhibitors of the STING pathway for the treatment of autoimmune, inflammatory, cardiovascular, metabolic, and neurodegenerative diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

STING pathway inhibitorssmall molecule therapeuticssmall molecule inhibitorsdrug discoverysmall molecule drugsbiotech startupimmunologymedicinal chemistrypreclinical developmentautoimmune disease treatmentinflammatory diseaseneurodegenerative diseasedrug pipelinebiotech licensingpharma partnership

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

STANT Comparables

Compare STANT with similar companies based on industry and business-model similarity.

STANT comparables — related companies by embedding similarity
Company	Similarity	Market Cap
iSD Immunotech	86%
ImmuneSensor Therapeutics	79%
IFM Therapeutics	79%

View all Comparables

STANT Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Nov 19, 2024

View all Funding Rounds

STANT Investors

Notable investors and investment history

STANT investors
Investor	Rounds
Brabantse Ontwikkelings Maatschappij	Seed
Brabantse Ontwikkelings Maatschappij	Seed
First Fund	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Nov 19, 2024
Seed round with participation from First Fund and Brabantse Ontwikkelings Maatschappij.

View all signals

STANT Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

STANT Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about STANT's valuation, stock price, and market status.

Firmographic Details

HeadquartersOss

Employee Range2

Year Founded2024

Last FundingNov 19, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?